All News

Treatment options for head live include Permethrin (Nix) and Pyrethrin (Rid) as OTC options and prescription medicines such as Ivermectin (Sklice), Spinosad (Natroba), and Malathion.

Pharmacists can review clinical evidence and CDC recommendations before providing information.

VOR33 aims to protect an individual’s healthy cells from anti-CD33 therapies and replace standard care transplants.

PT0271 improved lung function and reduced the risk of exacerbations in individuals with asthma.

Although most Americans live close to a pharmacy, vaccination rates remain suboptimal.

Improvements in moderate-to-severe atopic dermatitis began quickly after the first dose of dupilumab, with improved itching in 1 week and skin clearance in 2 weeks.

But will policy and program administrators make optimal use of existing primary care and pharmacy systems?

New research has found that the relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the PRONOUNCE trial was terminated early.

Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.

The results of a 5-year follow-up study comparing trastuzumab (Ontruzant) and reference medicine trastuzumab show comparable cardiac safety profiles and long-term efficacy.

Formulary changes, utilization management, and a lack of transparency upset a lot of members, which hides a lot of good things that pharmacy benefit managers do.

The findings, published in the Journal of the American Heart Association, add to a list of cardiac risks experienced by patients with HIV.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

There are many substances that are included on the prohibited list for the Tokyo Olympics that are considered standard medications for certain disease states.

The National Institutes of Health grants each entity $14.8 million in funding over the course of 5 years to conduct research into the progressive disease.

Crohn disease causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.

A panel of experts from various settings in the pharmacy field discuss the application of cultural humility and their own experiences when providing culturally appropriate care to underserved or marginalized populations.

These special immune system defense molecules help show which individuals are most at risk of needing intensive care and need to be monitored more closely, new study results show.

With CAR T-cell therapies showing promise for follicular lymphoma and marginal zone lymphoma, clinicians must weigh toxicity and tolerability almost as strongly as efficacy because patients can live years with these diseases

With COVID-19 vaccination clinics still operating and booster doses on the horizon, there continues to be a need for pharmacy technicians as immunizers well into the future.

Lola Fashoyin-Aje, MD, MPH, associate director of Science & Policy Program to Address Disparities at the FDA’s Oncology Center of Excellence, discusses the importance of promoting inclusion of members of racial and ethnic minority groups in cancer drug trials.

The European Association of Neuro-Oncology and the European Society for Medical Oncology published recommendations related to parenchymal brain metastases.

Dupilumab (Dupixent) was approved in 2017 for the treatment of adults with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies.

The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.

New artificial intelligence tool can identify tumors at a 97% rate, a year before other methods can diagnose it.

Results from POSEIDON, a randomized open label, phase 3 trial, showed that patients administered 5 cycles of tremelimumab plus durvalumab and chemotherapy over 16 weeks experienced a 23% reduction in the risk of death compared with various chemotherapy options.

Results of a new study show that the vaccines seldomly reach the area that were heavily affected by the pandemic, because of ethnic, racial, and socioeconomic disparities.

Study suggests potentially expanding the use of immunotherapies in the elderly, a population in whom these therapies may be under-prescribed.

Parents are encouraged to either get all immunizations in one health care facility or have a card that documents all the immunizations the child has received.

The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.